US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 0.230
  • -0.009-3.56%
Close Dec 20 16:00 ET
  • 0.233
  • +0.003+1.39%
Post 20:01 ET
12.69MMarket Cap-0.09P/E (TTM)

About Marinus Pharmaceuticals Company

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

Company Profile

SymbolMRNS
Company NameMarinus Pharmaceuticals
Listing DateJul 31, 2014
Issue Price8.00
Founded2003
CEODr. Scott Braunstein, M.D.
MarketNASDAQ
Employees165
Fiscal Year Ends12-31
Address5 Radnor Corporate Center,100 Matsonford Road,Suite 500
CityRadnor
ProvincePennsylvania
CountryUnited States of America
Zip Code19087-5279
Phone1-484-801-4670
Websitehttp://www.marinuspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Scott Braunstein, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 3.21M
  • Steven Pfanstiel, C.M.A.,M.B.A.
  • Chief Operating Officer, Chief Financial Officer and Treasurer
  • 1.44M
  • Christina Shafer
  • Chief Commercial Officer
  • --
  • Joseph Hulihan
  • Chief Medical Officer
  • 1.37M
  • Martha E. Manning, Esq.
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Christine Berni Silverstein
  • Independent Director
  • 249.21K
  • Elan Ezickson
  • Independent Director
  • 162.52K
  • Seth H.Z. Fischer
  • Independent Director
  • 160.02K
  • Timothy M. Mayleben
  • Lead Independent Director
  • 202.52K
  • Marvin H. Johnson, Jr
  • Independent Director
  • 304.81K
Heat List
US
Overall
Symbol
Price
% Chg

No Data